These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

494 related items for PubMed ID: 15871354

  • 1. Chemotherapy of leprosy.
    Biswas SK, WHO.
    J Indian Med Assoc; 2004 Dec; 102(12):695-6, 698. PubMed ID: 15871354
    [Abstract] [Full Text] [Related]

  • 2. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I, Cartel JL, Grosset JH.
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
    [Abstract] [Full Text] [Related]

  • 3. Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy.
    Villahermosa LG, Fajardo TT, Abalos RM, Cellona RV, Balagon MV, Dela Cruz EC, Tan EV, Walsh GP, Walsh DS.
    Am J Trop Med Hyg; 2004 Feb; 70(2):197-200. PubMed ID: 14993633
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
    Shaw IN, Christian M, Jesudasan K, Kurian N, Rao GS.
    Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
    [Abstract] [Full Text] [Related]

  • 5. Impact of multidrug therapy on leprosy in Baroda district (Gujarat).
    Chopra NK, Agarwal JS, Pandya PG.
    Indian J Lepr; 1989 Apr; 61(2):179-89. PubMed ID: 2746026
    [Abstract] [Full Text] [Related]

  • 6. Developing new MDT regimens for MB patients; time to test ROM 12 month regimens globally.
    Lockwood DN, Cunha Mda G.
    Lepr Rev; 2012 Sep; 83(3):241-4. PubMed ID: 23356024
    [No Abstract] [Full Text] [Related]

  • 7. [New WHO recommendations for the treatment of leprosy].
    Acta Leprol; 1997 Sep; 10(4):189. PubMed ID: 9527754
    [No Abstract] [Full Text] [Related]

  • 8. Single-dose treatment for paucibacillary leprosy; clinical problems and management.
    Pai VV, Bulchand HO, Revankar CR, Ganapati R.
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
    Majumder V, Saha B, Hajra SK, Biswas SK, Saha K.
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
    [Abstract] [Full Text] [Related]

  • 10. [Supervised bimonthly quadruple chemotherapy in 72 paucibacillary leprosy patients in French Guyana].
    Jamet P, Robin Y.
    Acta Leprol; 1988 Sep; 6(1):35-44. PubMed ID: 3051853
    [Abstract] [Full Text] [Related]

  • 11. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
    Groenen G, Janssens L, Kayembe T, Nollet E, Coussens L, Pattyn SR.
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962
    [Abstract] [Full Text] [Related]

  • 12. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
    Chandorkar AG, Burte NP, Gade RK, Bulakh PM.
    Indian J Lepr; 1984 Jun; 56(1):63-70. PubMed ID: 6384381
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of single-dose chemotherapy (rifampicin, ofloxacin and minocycline-ROM) in PB leprosy patients with 2 to 5 skin lesions, India: randomised double-blind trial.
    Manickam P, Nagaraju B, Selvaraj V, Balasubramanyam S, Mahalingam VN, Mehendale SM, Pannikar VK, Gupte MD, Team of Study Investigators.
    Indian J Lepr; 2012 Jun; 84(3):195-207. PubMed ID: 23484334
    [Abstract] [Full Text] [Related]

  • 14. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR, Shrestha K, Pandey B, Walker SL.
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [Abstract] [Full Text] [Related]

  • 15. A comparative clinico-pathological study of single dose ROM in paucibacillary leprosy patients with 1-3 skin lesions.
    Deshmukh AR, Dhurat RS, Jerajani HR.
    Indian J Lepr; 2003 Dec; 75(3):209-17. PubMed ID: 15267190
    [Abstract] [Full Text] [Related]

  • 16. Minocycline is effective and cosmetically preferred to clofazimine by leprosy patients in New York.
    Levis WR, Spencer TI, Ladizinski B.
    J Drugs Dermatol; 2010 Aug; 9(8):906. PubMed ID: 20684139
    [No Abstract] [Full Text] [Related]

  • 17. Hansen's disease in Portugal: multibacillary patients treated between 1988 and 2003.
    Medeiros S, Catorze MG, Vieira MR.
    J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):29-35. PubMed ID: 18713227
    [Abstract] [Full Text] [Related]

  • 18. OFLOXACIN multicentre trial in MB leprosy FUAM-Manaus and ILSL-Bauru, Brazil.
    Cunha Mda G, Virmond M, Schettini AP, Cruz RC, Ura S, Ghuidella C, Viana Fdos R, Avelleira JC, Campos AA, Filho B.
    Lepr Rev; 2012 Sep; 83(3):261-8. PubMed ID: 23356027
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK, Hazra SK, Chaudhury S, Chatterjee B.
    Indian J Lepr; 1984 Sep; 56(1):78-85. PubMed ID: 6548246
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of single dose multidrug therapy for the treatment of single-lesion paucibacillary leprosy. Single-lesion Multicentre Trial Group.
    Indian J Lepr; 1997 Sep; 69(2):121-9. PubMed ID: 9290963
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.